オマリズマブ
↑ “Xolair- omalizumab injection, solution Xolair PFS- omalizumab injection, solution”. DailyMed (2020年5月11日). 2020年12月6日閲覧。
↑ Schulman ES (October 2001). “Development of a monoclonal anti-immunoglobulin E antibody (omalizumab) for the treatment of allergic respiratory disorders”. Am J Respir Crit Care Med 164 (8 Pt 2): S6–11. doi:10.1164/ajrccm.164.supplement_1.2103025. PMID 11704611.
1 2 3 “Anti-IgE Antibodies for the Treatment of IgE-mediated Allergic Diseases”. Adv Immunol. Advances in Immunology 93: 63–119. (2007). doi:10.1016/S0065-2776(06)93002-8. ISBN 9780123737076. PMID 17383539.
1 2 “ゾレア皮下注用75mg/ゾレア皮下注用150mg 添付文書”. www.info.pmda.go.jp. 2021年3月27日閲覧。
1 2 3 Davydov, Liya (2005-01-15). “Omalizumab (Xolair) for Treatment of Asthma”.